Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 8577 - 8584 of 12086 results
Ransomware Strikes California Hospital - Could You Be Next?
February 23, 2016| Blog| Viewpoint
Groundbreaking Multi-Payer Alignment on Core Measures for Quality-Based Payments
February 23, 2016| Blog| Viewpoint
Provider Confusion and Interoperability Concerns Prompt OCR and ONC to Release Guidance on PHI Sharing
February 22, 2016| Blog| Viewpoint
Preemption Defense in the Ninth Circuit Is “Not Dead Yet”
February 19, 2016| Blog| Viewpoint
Health Care: What's on the Radar for This Congressional Work Period
February 19, 2016| Advisory| Viewpoint
2016 Wage & Hour Update – What Lies Ahead for California Employers?
February 19, 2016| Blog| Viewpoint
Visa-Waiver Program Further Restricted for Travelers of Libya, Somalia, and Yemen
February 19, 2016| Blog| Viewpoint
Hollywood Presbyterian Concedes to Hacker’s Demands in Ransomware Attack
February 19, 2016| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|